PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Committee opinion: no. 562: müllerian agenesis: diagnosis, management, and treatment.

Abstract Müllerian agenesis occurs in 1 out of every 4,000-10,000 females. The most common presentation of müllerian agenesis is congenital absence of the vagina, uterus, or both, which also is referred to as müllerian aplasia, Mayer-Rokitansky-Küster-Hauser syndrome, or vaginal agenesis. Satisfactory vaginal creation usually can be managed nonsurgically with successive vaginal dilation; however, there are a variety of surgical options for creation of a neovagina. Regardless of the treatment option selected, patients should be thoroughly counseled and prepared psychologically before the initiation of any treatment. Evaluation for associated congenital renal anomalies or other anomalies is also important. Although exact gynecologic screening recommendations are evolving, all women with a neovagina should undergo routine gynecologic care; however, vaginal cytologic screening is not indicated.
PMID
Related Publications

Using the Wharton-Sheares-George method to create a neovagina in patients with Mayer-Rokitansky-Küster-Hauser syndrome: a step-by-step video tutorial.

ACOG Committee Opinion No. 728 Summary: Müllerian Agenesis: Diagnosis, Management, And Treatment.

Mayer-Rokitansky-Kuster-Hauser syndrome: complications, diagnosis and possible treatment options: a review.

ACOG Committee Opinion No. 355: Vaginal agenesis: diagnosis, management, and routine care.

ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment.

Authors

Mayor MeshTerms
Keywords
Journal Title obstetrics and gynecology
Publication Year Start




PMID- 23635766
OWN - NLM
STAT- MEDLINE
DCOM- 20130701
LR  - 20130502
IS  - 1873-233X (Electronic)
IS  - 0029-7844 (Linking)
VI  - 121
IP  - 5
DP  - 2013 May
TI  - Committee opinion: no. 562: mullerian agenesis: diagnosis, management, and
      treatment.
PG  - 1134-7
LID - 10.1097/01.AOG.0000429659.93470.ed [doi]
AB  - Mullerian agenesis occurs in 1 out of every 4,000-10,000 females. The most common
      presentation of mullerian agenesis is congenital absence of the vagina, uterus,
      or both, which also is referred to as mullerian aplasia,
      Mayer-Rokitansky-Kuster-Hauser syndrome, or vaginal agenesis. Satisfactory
      vaginal creation usually can be managed nonsurgically with successive vaginal
      dilation; however, there are a variety of surgical options for creation of a
      neovagina. Regardless of the treatment option selected, patients should be
      thoroughly counseled and prepared psychologically before the initiation of any
      treatment. Evaluation for associated congenital renal anomalies or other
      anomalies is also important. Although exact gynecologic screening recommendations
      are evolving, all women with a neovagina should undergo routine gynecologic care;
      however, vaginal cytologic screening is not indicated.
CN  - Committee on Adolescent Health Care
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Obstet Gynecol
JT  - Obstetrics and gynecology
JID - 0401101
RN  - Mullerian aplasia
SB  - AIM
SB  - IM
MH  - 46, XX Disorders of Sex Development/*diagnosis/*surgery
MH  - Adolescent
MH  - Congenital Abnormalities/*diagnosis/*surgery
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Mullerian Ducts/*abnormalities/surgery
MH  - Young Adult
EDAT- 2013/05/03 06:00
MHDA- 2013/07/03 06:00
CRDT- 2013/05/03 06:00
PHST- 2013/05/03 06:00 [entrez]
PHST- 2013/05/03 06:00 [pubmed]
PHST- 2013/07/03 06:00 [medline]
AID - 10.1097/01.AOG.0000429659.93470.ed [doi]
AID - 00006250-201305000-00046 [pii]
PST - ppublish
SO  - Obstet Gynecol. 2013 May;121(5):1134-7. doi: 10.1097/01.AOG.0000429659.93470.ed.